https://avego.com/ 2026-11-04T22:31:11+00:00 https://avego.com/ribon-therapeutics-secures-65-million-financing/ 2021-10-12T12:12:53+00:00 https://avego.com/arch-oncology-secures-105-million-series-c-financing/ 2021-10-12T12:13:47+00:00 https://avego.com/caribou-biosciences-raises-115m-series-c-financing-to-advance-next-generation-crispr-technologies-and-allogeneic-cell-therapy-pipeline/ 2021-10-12T12:14:04+00:00 https://avego.com/santen-and-u-s-ophthalmic-company-eyevance-enter-into-share-purchase-agreement/ 2021-10-12T12:14:29+00:00 https://avego.com/antios-therapeutics-raises-75-million-in-a-series-b-1-funding-to-advance-clinical-programs-for-hbv/ 2021-11-03T09:33:03+00:00 https://avego.com/ellie-diagnostics-raises-growth-equity-from-avego-healthcare-capital/ 2021-11-10T09:47:18+00:00 https://avego.com/saol-therapeutics-announces-fda-approval-of-lyvispah-baclofen-oral-granules-and-the-divesture-of-its-plasma-derived-hyperimmune-portfolio/ 2021-12-13T10:51:31+00:00 https://avego.com/amneal-acquires-saol-therapeutics-baclofen-franchise/ 2022-01-05T10:30:59+00:00 https://avego.com/atomvie-global-radiopharma-inc-announces-its-spinout-and-series-a-financing-with-avego/ 2022-08-24T09:11:04+00:00 https://avego.com/escient-pharmaceuticals-announces-120-million-series-c-financing/ 2022-11-28T12:19:54+00:00 https://avego.com/pbs-biotech-raises-22m-to-expand-single-use-manufacturing-products-and-services-for-cell-therapy-clients/ 2023-01-09T11:07:49+00:00 https://avego.com/alimera-improves-capital-structure-strengthens-balance-sheet-and-extends-term-loan-facility/ 2023-03-27T09:21:34+00:00 https://avego.com/atomvie-global-radiopharma-raises-over-90m-to-complete-its-new-facility-buildout/ 2023-06-01T11:17:33+00:00 https://avego.com/ani-pharmaceuticals-to-further-expand-rare-disease-business-through-acquisition-of-alimera-sciences/ 2024-06-24T07:56:26+00:00 https://avego.com/evommune-announces-115-million-series-c-financing/ 2024-11-05T15:31:45+00:00 https://avego.com/alentis-therapeutics-raises-181-4-million/ 2024-11-12T09:44:50+00:00 https://avego.com/trexbio-announces-84-million-series-b-financing/ 2024-11-13T11:26:03+00:00 https://avego.com/pbs-biotech-expands-leadership-team-and-secures-17-million/ 2025-01-06T11:50:27+00:00 https://avego.com/maplight-therapeutics-announces-372-5-million-series-d-financing/ 2025-10-08T11:42:02+00:00 https://avego.com/cellcentric-secures-120-million-investment/ 2025-10-08T11:43:35+00:00 https://avego.com/jasper-therapeutics-and-amplitude-healthcare-acquisition-corporation-announce-merger-to-create-a-publicly-listed-leading-biotechnology-company-in-hematopoietic-stem-cell-transplantation/ 2025-10-08T11:44:27+00:00 https://avego.com/mytomorrows-raises-29-million/ 2025-11-11T11:40:47+00:00 https://avego.com/epibiologics-closes-107m-series-b/ 2026-01-26T14:17:41+00:00 https://avego.com/alveus-therapeutics-launches-with-160-million-series-a-financing/ 2026-01-26T14:18:58+00:00 https://avego.com/memento-medicines-launches-with-93-million-series-a-financing/ 2026-07-20T16:13:58+00:00 https://avego.com/opentrons-announces-40m-series-e-round/ 2026-10-29T11:54:45+00:00